📰 Second Genome News
Page 2 - Second Genome News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Second Genome. Real-time updates on events, politics, business and more.
March 3, 2023
Etrasimod was effective and well tolerated as an induction and maintenance therapy in patients with moderately to severely active ulcerative colitis. Etrasimod is a treatment option with a unique combination of attributes that might address the persistent unmet needs of patients with ulcerative colitis.
February 10, 2023
/PRNewswire/ -- The "Microbiome Therapeutics: Global Markets" report has been added to ResearchAndMarkets.coms offering. The global Microbiome Therapeutics...
January 6, 2023
The Business Research Companys Microbiome Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032
December 1, 2022
Human Microbiome Market Size will Escalate Rapidly in the Near Future
November 30, 2022
Human Microbiome Market Size will Escalate Rapidly in the Near Future
November 29, 2022
U.S. Human Microbiome Market is an unmatched market research report that conducts industry analysis on products, markets, companies, industries and many countries worldwide. This marketing report analyses market information related to specific stock, currency, commodity and geographic region or country. Such excelle...
November 24, 2022
/PRNewswire/ -- According to a new report published by UnivDatos Markets Insights, the Human Microbiome Market was valued at more than USD 380.6 million in...
November 24, 2022
NOIDA, India, Nov. 24, 2022 /PRNewswire/ -- According to a new report published by UnivDatos Markets Insights, the Human Microbiome Market was valued at more than USD 380.6 million
October 3, 2022
Global human microbiome sequencing market is estimated to exhibit a CAGR of 20.31% during the forecast period.
July 13, 2022
Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer - read this article along with other careers information, tips and advice on BioSpace